AU1800699A - Stereospecific delivery of a drug using electrotransport - Google Patents

Stereospecific delivery of a drug using electrotransport

Info

Publication number
AU1800699A
AU1800699A AU18006/99A AU1800699A AU1800699A AU 1800699 A AU1800699 A AU 1800699A AU 18006/99 A AU18006/99 A AU 18006/99A AU 1800699 A AU1800699 A AU 1800699A AU 1800699 A AU1800699 A AU 1800699A
Authority
AU
Australia
Prior art keywords
electrotransport
stereospecific
drug
delivery
stereospecific delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18006/99A
Other languages
English (en)
Inventor
Suneel K. Gupta
Rama Padmanabhan
Gayatri Sathyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AU1800699A publication Critical patent/AU1800699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
AU18006/99A 1997-12-01 1998-11-30 Stereospecific delivery of a drug using electrotransport Abandoned AU1800699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/982,245 US6136327A (en) 1997-12-01 1997-12-01 Stereospecific delivery of a drug using electrotransport
US08982245 1997-12-01
PCT/US1998/025387 WO1999027990A2 (en) 1997-12-01 1998-11-30 Stereospecific delivery of a drug using electrotransport

Publications (1)

Publication Number Publication Date
AU1800699A true AU1800699A (en) 1999-06-16

Family

ID=25528979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18006/99A Abandoned AU1800699A (en) 1997-12-01 1998-11-30 Stereospecific delivery of a drug using electrotransport

Country Status (7)

Country Link
US (1) US6136327A (enExample)
EP (1) EP1035891B1 (enExample)
JP (2) JP2001524364A (enExample)
AU (1) AU1800699A (enExample)
DE (1) DE69814147T2 (enExample)
ES (1) ES2198781T3 (enExample)
WO (1) WO1999027990A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI277418B (en) * 2001-06-18 2007-04-01 Noven Pharma Enhanced drug delivery in transdermal systems
US20040197397A1 (en) * 2002-08-30 2004-10-07 Watson Pharmaceuticals, Inc. Drug delivery system for treatment of urinary incontinence
AU2003285012A1 (en) * 2002-10-24 2004-05-13 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
WO2005011662A1 (ja) * 2003-07-31 2005-02-10 Hisamitsu Pharmaceutical Co., Inc. 貼付剤
US20120035203A1 (en) * 2009-04-27 2012-02-09 Cambria Pharmaceuticals, Inc. Butaclamol for the treatment of amyotrophic lateral sclerosis
CN110072437B (zh) * 2016-12-13 2022-04-08 阿莫生命科学有限公司 贴片型传感器模块
US10799138B2 (en) 2018-04-05 2020-10-13 University Of Maryland, Baltimore Method of administering sotalol IV/switch
CN108888593B (zh) * 2018-06-27 2021-09-21 济南康和医药科技有限公司 一种阿替洛尔注射液及其制备方法
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
JP2025096725A (ja) * 2022-05-30 2025-06-30 キッコーマン株式会社 経皮通電パッチ

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800162A (en) 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
US5114946A (en) * 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
US4818541A (en) * 1987-08-19 1989-04-04 Schering Corporation Transdermal delivery of enantiomers of phenylpropanolamine
US4927854A (en) * 1987-12-24 1990-05-22 Analgesic Associates Sustained/enhanced analgesia
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
ATE118208T1 (de) 1989-10-16 1995-02-15 Chiroscience Ltd Chirale azabicycloheptanone und verfahren zu ihrer herstellung.
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
DE69328042T2 (de) * 1992-12-31 2000-11-16 Alza Corp., Palo Alto Elektrotransporteinrichtung
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5516943A (en) 1993-09-14 1996-05-14 Sepracor, Inc. Process for preparing cyclic CIS-1-amino-2-alkanols
US5442118A (en) 1994-04-22 1995-08-15 Sepracor, Inc. Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones
US5545745A (en) 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
JPH11503043A (ja) * 1995-04-07 1999-03-23 ノバルティス・アクチエンゲゼルシャフト 少なくとも２種の被投与物を投与するためのイオン泳動性経皮システム
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5983130A (en) * 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
AU6657396A (en) * 1995-07-28 1997-02-26 Novartis Ag Transdermal system

Also Published As

Publication number Publication date
WO1999027990A2 (en) 1999-06-10
US6136327A (en) 2000-10-24
DE69814147T2 (de) 2004-03-18
EP1035891A1 (en) 2000-09-20
JP2007216053A (ja) 2007-08-30
DE69814147D1 (de) 2003-06-05
EP1035891B1 (en) 2003-05-02
ES2198781T3 (es) 2004-02-01
WO1999027990A3 (en) 1999-09-10
JP2001524364A (ja) 2001-12-04

Similar Documents

Publication Publication Date Title
AU740344C (en) Novel insulin derivatives having a rapid onset of action
AU5676596A (en) Oral insulin delivery
AU1302499A (en) Buffered drug formulations for transdermal electrotransport delivery
KR20010012511A (ko) 약리학적 활성 물질을 제조하기 위한 신규한 방법
AU5396496A (en) A vibrator
AU9252998A (en) Implant syringe
AU1061699A (en) Use of biologically active glass as a drug delivery system
AU1800699A (en) Stereospecific delivery of a drug using electrotransport
AU2337897A (en) Uniform drug delivery therapy
AU2559995A (en) Transdermal delivery of anti-epileptic drugs
AU6940998A (en) Phospholipid drug derivatives
AU7000496A (en) Anti-inflammatory antisense drug
AU8817398A (en) Method of drug selection
AU5326698A (en) New therapeutic use of a thienylcyclohexylamine derivative
AU5951798A (en) Oral application of (+)-O-demethyltramadol as a pain- killing drug
AU1143899A (en) Transdermal delivery of 3,4-diarylchromans
AU4333796A (en) A nutritive composition containing milt
AU1760799A (en) A gel-form pharmaceutical preparation
AU2447097A (en) Oral coated active drugs
AU1075795A (en) Adhesive patch for transdermal drug delivery
AU2343395A (en) A medical electrode
AU5327996A (en) A single use syringe
AU4335897A (en) Iontophoretic delivery of buprenorphine
AU6425498A (en) New anticonvulsant drugs
AU6387998A (en) Medicinal temporizer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase